Haematological malignancies: at the forefront of immunotherapeutic innovation.

ABSTRACT: The recent successes of cancer immunotherapies have stimulated interest in the potential widespread application of these approaches; haematological malignancies have provided both initial proofs of concept and an informative testing ground for various immune-based therapeutics. The immune-cell origin of many of the blood malignancies provides a unique opportunity both to understand the mechanisms of cancer immune responsiveness and immune evasion, and to exploit these mechanisms for therapeutic purposes.

SUBMITTER: Bachireddy P 

PROVIDER: S-EPMC4511812 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature